1Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation[J]. Biochem J, 2003,374(Pt 1) :1.
2Viereck V, Grundker C, Blaschke S, et al. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts[J]. J Clin Endocrinol Metab, 2003, 88(9) :4206.
3Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al.Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause[J]. J Clin Endocrinol Metab, 2001, 86(5):2032.
4Bellido T, Jilka RL, Boyee BF, et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor[J]. J Clin Invest, 1995,(6) :2886.
5Feng D, Ishibashi H, Yamamoto S, et al. Association between bone loss and promoter polymorphism in the IL-6 gene in elderly Japanese women with hip fracture[J]. J Bone Miner Metab, 2003, 21(4) :225.
6Chung HW, Seo JS, Hur SE, et al. Association of interleukin-6 promoter variant with bone mineral density inpre-menopausal women[J]. J Hum Genet, 2003, 48(5) :243.
7Yamada Y, Ando F, Niino N, et al. Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men[J]. J Clin Endocrinol Metab, 2003, 88(7):3372.
8Ota N, Nakajima T, Nakazawa I, et al. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density[J]. J Hum Genet, 2001, 46(5) :267.
9Ferrari SL, Garnero P, Emond S, et al. A functional polymorphic variant in the interleukin-6 gene promoter associatedwith low bone resorption in postmenopausal women[J]. Arthritis Rheum, 2001, 44(1) :196.
10Nordstrom A, Gerdhem P, Brandstrom H, et al. Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women[G]. Osteoporos Int,2004,15(10) :820.
5Alejandro Erices,Paulette Conget,Cecilia Rojas,José J. Minguell.gp130 Activation by Soluble Interleukin-6 Receptor/Interleukin-6 Enhances Osteoblastic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells[J]. Experimental Cell Research . 2002 (1)
